|
|||||
|
|
Novel function for the p38‐MK2 signaling pathway in circulating CD1c+ (BDCA‐1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL‐12 whilst suppressing IL‐10 |
|
| Authors: | Hester A. Franks Qunwei Wang Stephanie J. Lax Mary K. Collins David Escors Poulam M. Patel Andrew M. Jackson |
| Affiliation: | 1. Host:Tumour Interactions Group, Academic Unit of Clinical Oncology University of Nottingham, United Kingdom;2. MRC Centre for Medical Molecular Virology, University College London, United Kingdom;3. Immunomodulation group, Navarrabiomed‐Fundacion Miguel Servet National Health Service of Navarre, Pamplona, Navarra, Spain |
| Abstract: | |
| Keywords: | dendritic cell signaling IL‐12 Th1 p38 |